These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


575 related items for PubMed ID: 9293918

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States).
    Wu AH, Wan P, Bernstein L.
    Cancer Causes Control; 2001 Oct; 12(8):721-32. PubMed ID: 11562112
    [Abstract] [Full Text] [Related]

  • 3. Population attributable risks of esophageal and gastric cancers.
    Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF.
    J Natl Cancer Inst; 2003 Sep 17; 95(18):1404-13. PubMed ID: 13130116
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden.
    Bahmanyar S, Ye W.
    Nutr Cancer; 2006 Sep 17; 54(2):171-8. PubMed ID: 16898861
    [Abstract] [Full Text] [Related]

  • 9. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.
    Figueroa JD, Terry MB, Gammon MD, Vaughan TL, Risch HA, Zhang FF, Kleiner DE, Bennett WP, Howe CL, Dubrow R, Mayne ST, Fraumeni JF, Chow WH.
    Cancer Causes Control; 2009 Apr 17; 20(3):361-8. PubMed ID: 18989634
    [Abstract] [Full Text] [Related]

  • 10. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia.
    Kabat GC, Ng SK, Wynder EL.
    Cancer Causes Control; 1993 Mar 17; 4(2):123-32. PubMed ID: 8481491
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors.
    Zhang ZF, Kurtz RC, Sun M, Karpeh M, Yu GP, Gargon N, Fein JS, Georgopoulos SK, Harlap S.
    Cancer Epidemiol Biomarkers Prev; 1996 Oct 17; 5(10):761-8. PubMed ID: 8896886
    [Abstract] [Full Text] [Related]

  • 13. Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study.
    Gammon MD, Terry MB, Arber N, Chow WH, Risch HA, Vaughan TL, Schoenberg JB, Mayne ST, Stanford JL, Dubrow R, Rotterdam H, West AB, Fraumeni JF, Weinstein IB, Hibshoosh H.
    Cancer Epidemiol Biomarkers Prev; 2004 Jan 17; 13(1):34-9. PubMed ID: 14744730
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between body mass and adenocarcinoma of the esophagus and gastric cardia.
    Lagergren J, Bergström R, Nyrén O.
    Ann Intern Med; 1999 Jun 01; 130(11):883-90. PubMed ID: 10375336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.